Academic literature on the topic 'Global diseases'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Global diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Global diseases"

1

Dr Sivanarayanan T B, Dr Sivanarayanan T. B., Dr Vysakh Mohan, Dr Muhasin Asaf V N, Dr Susanth V. S. Dr Susanth V S, and Dr Renjith Sebastian. "Global Warming: Impact on Animal Diseases." Global Journal For Research Analysis 3, no. 7 (June 15, 2012): 92–93. http://dx.doi.org/10.15373/22778160/july2014/108.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Yach, D. "Global Chronic Diseases." Science 307, no. 5708 (January 21, 2005): 317. http://dx.doi.org/10.1126/science.307.5708.317.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Woolhouse, Mark E. J. "Emerging diseases go global." Nature 451, no. 7181 (February 2008): 898–99. http://dx.doi.org/10.1038/451898a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Beaglehole, Robert, and Richard Horton. "Chronic diseases: global action must match global evidence." Lancet 376, no. 9753 (November 2010): 1619–21. http://dx.doi.org/10.1016/s0140-6736(10)61929-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sciarra, J. J. "Sexually transmitted diseases: global importance." International Journal of Gynecology & Obstetrics 58, no. 1 (July 1997): 107–19. http://dx.doi.org/10.1016/s0020-7292(97)02867-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rosenthal, Philip J. "Communicable Diseases: A Global Perspective." American Journal of Tropical Medicine and Hygiene 95, no. 4 (October 5, 2016): 974–75. http://dx.doi.org/10.4269/ajtmh.16-0624.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Trouiller, Patrice. "Global burden of tropical diseases." Lancet 346, no. 8984 (November 1995): 1233. http://dx.doi.org/10.1016/s0140-6736(95)92942-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kirsten, D., and U. Costabel. "Orphan Diseases - a Global Problem." Pneumologie 58, no. 10 (October 2004): 707–8. http://dx.doi.org/10.1055/s-2004-830054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Shinoda, Sumio. "Chronology of Major Global Diseases." Journal of Disaster Research 2, no. 2 (April 1, 2007): 110–13. http://dx.doi.org/10.20965/jdr.2007.p0110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Heymann, David. "Global Surveillance of Communicable Diseases." Emerging Infectious Diseases 4, no. 3 (September 1998): 362–65. http://dx.doi.org/10.3201/eid0403.980305.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Global diseases"

1

Mableson, Hayley Elizabeth. "The disease-scape of the new millennium : a review of global health advocacy and its application." Thesis, University of Edinburgh, 2014. http://hdl.handle.net/1842/17855.

Full text
Abstract:
The global disease scape is constantly shifting, influenced by demographic transitions, altering the balance of the burden of infectious and non‐communicable diseases. The epidemiological transitions can be divided into three stages: the first, an increase in infectious disease burden as populations settled, then grew into towns and cities providing conditions for infectious agents to maintain spread; the second transition follows industrialisation, changes in lifestyle, diet and improved sanitation whereby infectious diseases are reduced and non‐communicable disease (NCD) prevalence increases; the third transition describes the re‐emergence of infectious diseases as the AIDS epidemic and other emerging and re‐emerging disease outbreaks lead to an increasing burden of infectious diseases, particularly in developing countries. Analysis of the disease‐scape has been carried out using WHO Global Burden of Disease data and correlation to demographic factors calculated using World Bank Development Indicators. The balance of chronic NCDs and infectious diseases can be represented numerically as the unit rate of infectious to non‐communicable diseases. The rate, which indicates at which end the continuum lies can then be correlated to these demographic development indicators to assess the factors which are influential to the continuum. As the balance of infectious and non‐communicable diseases around the world alters, the focus of the advocacy at the global health level has been examined to assess if the trends follow that of the shifting continuum. This has been carried out through an assessment of the WHO World Health Assembly (WHA) resolutions adopted annually between 1948 and 2013 on the subject of infectious and/or non-communicable diseases. The principle of International health stemmed from the need to contain the international spread of communicable diseases, so it is not surprising that in the first decade of the WHO, 88% of the resolutions adopted for infectious and non‐communicable disease were adopted for infectious diseases. In the latest ten years of the WHO, 72% of the Assembly resolutions for infectious and non‐communicable diseases were focused on infectious diseases; this indicates that while there has been a shift in the balance, the adopted resolutions still focus heavily on infectious diseases. An example of how advocacy can elevate diseases to a higher position on the global health agenda is that of the Neglected Tropical Diseases. Following the Millennium Development Goals, this group of seventeen diseases has been highlighted as being “neglected” in terms of funding, research and political will. A review of the campaign to highlight this shows how global health advocacy can elevate diseases to a prominent position on the global health agenda. With this in mind, the advocacy for a sub‐group of Neglected Zoonotic Diseases has been examined at the WHA level. The results highlight the sporadic nature of support to control these diseases, and that activism for control of some of the major zoonotic diseases remains lacking. Rabies is explored as an example of a disease for which there are recommendations and support at the global level for the control and elimination of the disease, but for which barriers to control exist locally in endemic countries. The advocacy for diseases at the global health level has the possibility to impact the priorities of health care within individual nations. However the advocacy at this level may take time to reflect the changes within the disease‐scape. The impact of such advocacy is also limited by local political will, availability of resources and local cultural implications. Therefore there is a need to ensure that efforts to control diseases are tailored to specific populations and that resources are made available to support the advocacy.
APA, Harvard, Vancouver, ISO, and other styles
2

Pearson, Georgina. "Global health, local realities : neglected diseases in northwestern Uganda." Thesis, London School of Economics and Political Science (University of London), 2015. http://etheses.lse.ac.uk/3303/.

Full text
Abstract:
This thesis explores the everyday realities of neglected diseases among people living and working along the River Nile in Moyo and Adjumani Districts, northwestern Uganda. It is based on ethnographic-epidemiological fieldwork carried out over sixteen months during 2013 and 2014. The fieldwork included participant-observation, in-depth interviews and a parasitological survey with structured questionnaire. This thesis takes an interdisciplinary approach in studying global health, contributing to literature at the intersection between medicine and anthropology. The neglected tropical diseases are a group of diverse diseases framed in global health around common socio-economic-political features, persisting in poverty. They affect neglected populations, neglected by public health policy. Current approaches to their management are largely a collection of technical, diseasefocused programmes that disregard the politics of poverty. Contemporary debates surround the side-lining of social science literature, and the evidence behind the biomedically focussed disease control programmes. Fisherfolk are said to be vulnerable to a number of these diseases. Diseases such as intestinal schistosomiasis (one of the neglected tropical diseases) persist in fishing areas despite a global public health programme. However, as this study demonstrates, in northwestern Uganda levels of schistosomiasis infection appear to have reduced. This study situates the success of the global health control programme within the local biosocial context. Furthermore, it shows that while one neglected tropical disease is controlled, other diseases persist and emerge. These other diseases explored in this research were Buruli ulcer and Hepatitis B, diseases that challenged the global health concept of neglected tropical diseases. This thesis contributes methodologically to the growing interdisciplinary field of global health. It provides empirically-based biosocial evidence of the local realities of neglected diseases. In taking this approach, it argues that this concept is misleading. While it has illuminated particular problems in global health, the restrictive gaze disregards local public health concerns.
APA, Harvard, Vancouver, ISO, and other styles
3

Carinelli, Soledad. "Biomarkers detection of global infectious diseases based on magnetic particles." Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/667765.

Full text
Abstract:
Las enfermedades infecciosas suponen una gran amenaza para la salud mundial debido a la rápida diseminación y adaptación de los patógenos. El papel principal del diagnóstico clínico es identificar de forma fehaciente una enfermedad en un paciente. Los dispositivos de diagnóstico rápido permiten detectar enfermedades y monitorearlas de forma confiable en cualquier centro sanitario. Entre estos dispositivos, los biosensores electroquímicos presentan una alta sensibilidad y especificidad así como una instrumentación sencilla, pudiendo expandirse fácilmente a plataformas de detección múltiple. Además, la integración de partículas magnéticas (MPs) en métodos de diagnóstico rápido incrementa la sensibilidad y especificidad debido su capacidad para aislar y preconcentrar una molécula diana cuando éstas son modificadas con elementos de bioreconocimiento específico. Así, las MPs modificadas pueden unirse específicamente a biomarcadores y concentrarlos de muestras complejas bajo la actuación magnética, eliminando posibles interferencias. En esta tesis se presenta el desarrollo de estrategias de diagnóstico basados en tecnologías emergentes, asequibles y que requieren un entrenamiento mínimo de los usuarios finales, tales como los biosensores electroquímicos con accionamiento magnético. Primero, se presentan dos tipos de pruebas diagnósticas para la cuantificación de linfocitos CD4 en sangre entera, usando MPs, para el seguimiento rápido de pacientes con HIV en entornos de bajos recursos. Se describen dos formatos, uno en formato tipo ELISA con detección óptica y otro usando electrodos de grafito-epoxi con biosensado electroquímico. En ambos casos la estrategia involucra a) el aislamiento de células CD4 usando MPs-antiCD3 y su marcación utilizando anticuerpos antiCD4 biotinilados; b) la marcación enzimática con estreptavidina-peroxidasa; y c) la detección basada en la actividad enzimática. Esta doble marcación (a través de los receptores CD3 yCD4) no sólo evita interferencias de otras células que expresan alguno de estos receptores, sino que aumenta la especificidad del ensayo. Segundo, se describe un ensayo de liberación de interferon-basado en la detección electroquímica de dicho trascripto producido por linfocitos T previamente aislados de sangre. Este test utiliza MPs para el aislamiento y preconcentración de tres dianas diferentes (linfocitos T, mRNA y ADN doblemente marcado) en el mismo ensayo. Primero, los linfocitos T se aislan usando MPs-antiCD3. En segundo lugar, el mRNA de los linfocitos se preconcentra sobre MPs modificadas con polidT mediante unión a la cola de poli(A). Posteriormente se retrotranscribe el mRNA y se amplifica el cDNA mediante PCR múltiplex con marcación doble para la amplificación de IFN- y GAPDH. Finalmente, se inmovilizan los amplicones biotinilados en MPs-estreptavidina, y se realiza el genosensado electroquímico para la detección de IFN- a través del otro marcador del cebador. Esta estrategia se propone como alternativa a los ensayos de liberación de IFN- que se usan en la actualidad para la identificación de la Tuberculosis. Por último, se presenta el diseño de un test de diagnóstico rápido, específico y altamente sensible basado en la amplificación isotérmica sobre MPs con detección electroquímica. Las técnicas de amplificación isotérmicas han surgido como una alternativa a la PCR para la identificación de microorganismos infecciosos, debido a la barrera que éstos últimos muestran para su implementación en entornos de bajos recursos. El último capítulo presenta la detección electroquímica de ADN usando sondas candado con amplificación isotérmica de círculo rodante y amplificación círculo a círculo. Esta estrategia ha demostrado ser una poderosa herramienta para la detección específica y sensible de ácidos nucleicos para su aplicación en el diagnóstico clínico. Los biosensores desarrollados en esta tesis representan una gran promesa para la detección de forma más rápida, simple y económica comparado con los métodos tradicionales de diagnóstico de enfermedades infecciosas. Además, las estrategias desarrolladas en esta tesis demuestran un gran potencial para su aplicación en entornos de bajos recursos.
Infectious diseases are becoming a major threat worldwide due to the fast dissemination and adaptation of pathogens favored by the unrestricted globalization. The primary role of diagnostics is to identify a disease. The rapid identification of a disease allows the patient to be placed on a specific antimicrobial therapy and avoid prolonged management on empiric, potentially inappropriate drug. Therefore, point-of-care (POC) devices that can reliably detect and/or monitor diseases would result in an improved care, and minimization of patient and societal cost of illness. Among them, electrochemical biosensors have the advantage of high sensitivity/specificity as well as simplicity of instrumentation, and can be easily expanded to multiplex detection platform. Furthermore, the integration of magnetic particles (MPs) in POC tests provides an even increased sensitivity and specificity due to the isolation and preconcentration of the target, whether MPs are modified with a specific recognition biomolecule. Modified-MPs can thus specifically bind the biomarkers and preconcentrate them from the complex specimen under magnetic actuation, preventing interferents before testing. Affordable emerging technologies requiring minimal training for final users, such as magnetic actuated electrochemical biosensors, are presented in this dissertation. Firstly, two simple diagnostic tests for CD4+ T lymphocytes quantification, directly in whole blood, and based on magnetic particles are presented. The assay is performed in an ELISA-like format for the optical detection or using graphite-epoxy electrodes for the electrochemical biosensing strategy. In both cases, the strategy has involved three main steps: a) immunomagnetic separation of CD4+ cells by antiCD3-MPs and labeling by using biotinylated antiCD4 antibody; b) enzymatic labeling; and c) detection based on the peroxidase activity. The dual labeling (CD3 and CD4 receptor) not only avoids interferences of other cells, but also increases the specificity of the assay. Thus, the development and evaluation of magnetic-actuated rapid HIV diagnostic platforms appropriate for their use in low resource settings for the following-up of patients under treatment is demonstrated. Secondly, an interferon- release assay based on electrochemical detection for interferon- transcript detection produced by isolated T lymphocytes is described. This approach also involves the integration of MPs for the isolation and preconcentration of three different targets (including whole T lymphocytes, mRNA transcripts and double-tagged DNA) in the same test. Accordingly, T lymphocytes are isolated from whole blood using antiCD3-MPs. Secondly, mRNA presenting poly(A) tail is preconcentrated on polydT-MPs from T lymphocyte. Afterward, mRNA is retrotranscripted and cDNA amplified by multiplex double-tagging PCR for the specific amplification of IFN- and GAPDH. Finally, one of the tags of the primers is used for the amplicons immobilization on streptavidin-MPs as support, while the electrochemical magneto-genosensing for transcript detection is performed using the other tag. This strategy results in an alternative for IFN- release assays, which can be used for identifying infectious states such as Tuberculosis. Finally, the design of a diagnostic test involving a rapid, specific and highly sensitive procedure based on isothermal amplification on MPs with electrochemical readout is presented. Isothermal amplification techniques are emerging as good candidates to replace PCR for the identification of infectious microorganism, since PCR-based method can be a critical barrier in low resource settings. An electrochemical DNA detection using padlock probes and the subsequent amplification with rolling circle and circle to circle amplification is presented in Chapter 6. This strategy has demonstrated to be a powerful combination for highly specific and sensitive nucleic acid detection that can be applied in clinical diagnosis. The electrochemical biosensors developed in this dissertation, offers considerable promise for obtaining information in a faster, simpler and cheaper manner compared to traditional methods for infectious disease diagnosis. Moreover, the strategies possess great potential in many applications, in low resource settings.
APA, Harvard, Vancouver, ISO, and other styles
4

Wen, Allisandra. "Global interaction patterns and disease transmission a case study of China /." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43786005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Brown, J. K. "Diversity and Global Distribution of Whitefly-Transmitted Geminiviruses of Cotton." College of Agriculture, University of Arizona (Tucson, AZ), 1998. http://hdl.handle.net/10150/210399.

Full text
Abstract:
Geminivirus diseases of cotton are on the rise, worldwide, yet few have been studied in adequate detail to permit the implementation of rational approaches to disease control. The rising costs of managing the whitefly vector, coupled with substantial losses caused by geminivirus-incited diseases now hinder cotton production by requiring inputs that are beyond economic feasibility. The need for geminivirus disease resistant cultivars in diverse cotton producting areas and against different viral genotypes presents a new challenge. To meet this need, information about the identity, distribution, and relevant biotic characteristics of cotton -infecting geminiviruses is needed This project addresses this problem through the molecular analysis of the genomes of cotton-infecting geminivirus from cotton throughout the world Here, sequence similarities of the coat protein gene and of the non-coding IR/CR involved in regulating virus replication and transcription were examined by comparative sequence analysis to achieve virus identification. This is the first effort to determine virus identity and to map the distribution of geminiviruses on a global basis. The outcome of this effort will be a data base containing biotic and molecular information that will permit rapid and accurate geminivirus identification, and the selection of relevant viral species for development of cotton cultivars with disease resistance to the geminiviruses specific to individual production areas.
APA, Harvard, Vancouver, ISO, and other styles
6

Manousopoulou, Antigoni. "Development of a global quantitative proteomics methodology and clinical applications in chronic diseases." Thesis, University of Southampton, 2018. https://eprints.soton.ac.uk/427726/.

Full text
Abstract:
Shotgun proteomics refers to the untargeted and unbiased analysis of the global proteome as this occurs in a biological system. The overarching aim of my research is to develop a proteomics methodology for the in-depth profiling of tissue and cell-lines and apply this novel methodology in mouse model and human samples in order to identify molecular mechanisms and novel therapeutic targets of obesity and obesity-related chronic diseases, including Alzheimer's disease and oesophageal adenocarcinoma. The innovative quantitative proteomics methodology we developed for the global, untargeted proteomic profiling of cell lines and tissue has wide applications in different subject areas of biomedical research. Depending on the samples analysed and experimental design, this methodological approach can provide novel insight into physiological processes, the pathophysiology of disease, as well as identify novel therapeutic targets and disease markers.
APA, Harvard, Vancouver, ISO, and other styles
7

Wen, Allisandra, and 溫佩凝. "Global interaction patterns and disease transmission: a case study of China." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43786005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Guilloux, Alain. "Humanitarianism in national and global governance: a study of Taiwan's responses to diseases anddisasters." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2006. http://hub.hku.hk/bib/B37894237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Guilloux, Alain. "Humanitarianism in national and global governance a study of Taiwan's responses to diseases and disasters /." Click to view the E-thesis via HKUTO, 2006. http://sunzi.lib.hku.hk/hkuto/record/B37894237.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Abajobir, Amanuel Alemu, Kalkidan Hassen Abate, Cristiana Abbafati, Kaja M. Abbas, Foad Abd-Allah, Rizwan Suliankatchi Abdulkader, Abdishakur M. Abdulle, et al. "Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016." Elsevier, 2017. http://hdl.handle.net/10150/625868.

Full text
Abstract:
Background As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016. Methods We estimated prevalence and incidence for 328 diseases and injuries and 2982 sequelae, their non-fatal consequences. We used DisMod-MR 2.1, a Bayesian meta-regression tool, as the main method of estimation, ensuring consistency between incidence, prevalence, remission, and cause of death rates for each condition. For some causes, we used alternative modelling strategies if incidence or prevalence needed to be derived from other data. YLDs were estimated as the product of prevalence and a disability weight for all mutually exclusive sequelae, corrected for comorbidity and aggregated to cause level. We updated the Socio-demographic Index (SDI), a summary indicator of income per capita, years of schooling, and total fertility rate. GBD 2016 complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). Findings Globally, low back pain, migraine, age-related and other hearing loss, iron-deficiency anaemia, and major depressive disorder were the five leading causes of YLDs in 2016, contributing 57.6 million (95% uncertainty interval [UI] 40.8-75.9 million [7.2%, 6.0-8.3]), 45.1 million (29.0-62.8 million [5.6%, 4.0-7.2]), 36.3 million (25.3-50.9 million [4.5%, 3.8-5.3]), 34.7 million (23.0-49.6 million [4.3%, 3.5-5.2]), and 34.1 million (23.5-46.0 million [4.2%, 3.2-5.3]) of total YLDs, respectively. Age-standardised rates of YLDs for all causes combined decreased between 1990 and 2016 by 2.7% (95% UI 2.3-3.1). Despite mostly stagnant age-standardised rates, the absolute number of YLDs from non-communicable diseases has been growing rapidly across all SDI quintiles, partly because of population growth, but also the ageing of populations. The largest absolute increases in total numbers of YLDs globally were between the ages of 40 and 69 years. Age-standardised YLD rates for all conditions combined were 10.4% (95% UI 9.0-11.8) higher in women than in men. Iron-deficiency anaemia, migraine, Alzheimer's disease and other dementias, major depressive disorder, anxiety, and all musculoskeletal disorders apart from gout were the main conditions contributing to higher YLD rates in women. Men had higher age-standardised rates of substance use disorders, diabetes, cardiovascular diseases, cancers, and all injuries apart from sexual violence. Globally, we noted much less geographical variation in disability than has been documented for premature mortality. In 2016, there was a less than two times difference in age-standardised YLD rates for all causes between the location with the lowest rate (China, 9201 YLDs per 100 000, 95% UI 6862-11943) and highest rate (Yemen, 14 774 YLDs per 100 000, 11 018-19 228). Interpretation The decrease in death rates since 1990 for most causes has not been matched by a similar decline in age-standardised YLD rates. For many large causes, YLD rates have either been stagnant or have increased for some causes, such as diabetes. As populations are ageing, and the prevalence of disabling disease generally increases steeply with age, health systems will face increasing demand for services that are generally costlier than the interventions that have led to declines in mortality in childhood or for the major causes of mortality in adults. Up-todate information about the trends of disease and how this varies between countries is essential to plan for an adequate health-system response. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Global diseases"

1

Walker, David H., ed. Global Infectious Diseases. Vienna: Springer Vienna, 1992. http://dx.doi.org/10.1007/978-3-7091-3449-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

National Research Council (U.S.). Board on Agriculture and Natural Resources., ed. Emerging animal diseases: Global markets, global safety : a workshop summary. Washington, D.C: National Academy Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Communicable diseases: A global perspective. 4th ed. Wallingford, Oxfordshire, UK: CAB International, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Webber, R., ed. Communicable diseases: a global perspective. Wallingford: CABI, 2012. http://dx.doi.org/10.1079/9781845939397.0000.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Webber, R., ed. Communicable diseases: a global perspective. Wallingford: CABI, 2016. http://dx.doi.org/10.1079/9781780647425.0000.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Webber, R., ed. Communicable diseases: a global perspective. Wallingford: CABI, 2020. http://dx.doi.org/10.1079/9781786395245.0000.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

H, Calisher Charles, and Keystone J. S, eds. Exotic viral diseases: A global guide. Hamilton, Ont: B C Decker, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Elliott, Karen, and Donna A. Champeau. AIDS and STIs: A global perspective. New York: Learning Solutions, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Communicable disease epidemiology and control: A global perspective. 3rd ed. Wallingford, Oxfordshire: CABI, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Global health: Diseases, programs, systems, and policies. 3rd ed. Burlington, MA: Jones & Bartlett Learning, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Global diseases"

1

Kanki, Phyllis J. "HIV/AIDS Global Epidemic." In Infectious Diseases, 27–62. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5719-0_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gosselin, Richard A., Stephen W. Bickler, and Ali A. Ahmed Al-Iedan. "Tropical Diseases and Orthopedics." In Global Orthopedics, 57–66. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-13290-3_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gosselin, Richard A., Stephen W. Bickler, and Ali A. Ahmed Al-Iedan. "Tropical Diseases and Orthopedics." In Global Orthopedics, 57–67. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-1578-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bose, S., and J. P. Ortonne. "Diseases Affected by Heat." In Global Dermatology, 83–92. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4612-2614-7_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Amer, Mohamed. "Diseases Among Arab People." In Global Dermatology, 114–19. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4612-2614-7_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Green, Allen C. "Diseases Among Australian Aborigines." In Global Dermatology, 120–36. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4612-2614-7_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kostelnik, K. Erik, and Chérie M. Ditre. "Diseases Among Black People." In Global Dermatology, 137–53. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4612-2614-7_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Feinstein, Abraham. "Diseases Among Jewish People." In Global Dermatology, 154–63. New York, NY: Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4612-2614-7_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Walker, David H. "Rickettsial Diseases: From Epidemiology to Molecular Biology, The Pathway Toward Disease Control." In Global Infectious Diseases, 75–86. Vienna: Springer Vienna, 1992. http://dx.doi.org/10.1007/978-3-7091-3449-8_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

De Maio, Fernando. "Neglected Tropical Diseases." In Global Health Inequities, 78–102. London: Macmillan Education UK, 2014. http://dx.doi.org/10.1007/978-1-137-40063-5_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Global diseases"

1

Mikler, Armin R., Angel Bravo-Salgado, and Courtney D. Corley. "Global Stochastic Contact Modeling of Infectious Diseases." In 2009 International Joint Conference on Bioinformatics, Systems Biology and Intelligent Computing. IEEE, 2009. http://dx.doi.org/10.1109/ijcbs.2009.84.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Davis-Street, Janis, Perla Manlapaz, Amelia Shannon, and Olubukunola Adebola Fagade. "Addressing Cardiovascular Disease Global Employer's Approach to Non- Communicable Diseases." In International Conference on Health, Safety and Environment in Oil and Gas Exploration and Production. Society of Petroleum Engineers, 2012. http://dx.doi.org/10.2118/156849-ms.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chaban, Victor V. "Chronic Pain Associated with Functional Diseases." In 6th Annual Global Healthcare Conference (GHC 2017). Global Science & Technology Forum (GSTF), 2017. http://dx.doi.org/10.5176/2251-3833_ghc17.63.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zakizade, A. E., and G. I. Gurbanalieva. "Clinical and therapeutic aspects of inflammatory periodontal diseases." In Global science. Development and novelty. НИЦ «Л-Журнал», 2019. http://dx.doi.org/10.18411/gdsn-25-12-2019-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yadav, Anjali, Vandana Rohokale, and Sanjivani Shah. "Healing of Cardiovascular Diseases Through Mind-Heart Interaction." In 2018 Global Wireless Summit (GWS). IEEE, 2018. http://dx.doi.org/10.1109/gws.2018.8686624.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wang, Xinrong, Weijie Ma, Nan Li, Xiaocong Lian, Letian Zhu, Si Sun, Chen Chen, and Yongsan Zeng. "Risk Analysis on Cycad Diseases in a Global World." In CYCAD 2011. The New York Botanical Garden Press, 2018. http://dx.doi.org/10.21135/893275389.025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Melament, Alexander, Yardena Peres, Edward Vitkin, Igor Kostirev, Noam Shmueli, Luca Sangiorgi, Marina Mordenti, and Sergio D'Ascia. "BioMIMS - SOA Platform for Research of Rare Hereditary Diseases." In 2011 Annual SRII Global Conference (SRII). IEEE, 2011. http://dx.doi.org/10.1109/srii.2011.19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

YAMAGUCHI, TAKAMI, HITOSHI KONDO, YUJI SHIMOGONYA, YOHSUKE IMAI, NORIAKI MATSUKI, and TAKUJI ISHIKAWA. "COMPUTATIONAL BIOMECHANICS FOR INVESTIGATING CARDIOVASCULAR DISEASES." In Proceedings of the Tohoku University Global Centre of Excellence Programme. PUBLISHED BY IMPERIAL COLLEGE PRESS AND DISTRIBUTED BY WORLD SCIENTIFIC PUBLISHING CO., 2009. http://dx.doi.org/10.1142/9781848163539_0004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

M. Adel, Serhani, Elarbi Badidi, and Abdelghani Benharref. "SOA based E-Health System for Chronic Diseases Monitoring, Tracking, and Prevention." In Annual Global Healthcare Conference. Global Science and Technology Forum (GSTF), 2012. http://dx.doi.org/10.5176/2251-3833_ghc12.54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Govardhan, Meghana, and Veena M B. "Diagnosis of Tomato Plant Diseases using Random Forest." In 2019 Global Conference for Advancement in Technology (GCAT). IEEE, 2019. http://dx.doi.org/10.1109/gcat47503.2019.8978431.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Global diseases"

1

RUSHTON, J., T. BERNARDO, M. BRUCE, C. BELLET, P. TORGERSON, A. P. M. SHAW, M. HERRERO, et al. Global Burden of Animal Diseases – building a community of practice for animal health economics. O.I.E (World Organisation for Animal Health), December 2019. http://dx.doi.org/10.20506/bull.2019.nf.3035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ng, Shu Wen, Thomas Hoerger, and Rachel Nugent. Preventing Non-communicable Diseases Using Pricing Policies: Lessons for the United States from Global Experiences and Local Pilots. RTI Press, May 2021. http://dx.doi.org/10.3768/rtipress.2021.pb.0025.2105.

Full text
Abstract:
Preventing non-communicable diseases (NCDs) in an effective and sustainable way will require forward-looking policy solutions that can address multiple objectives. This was true pre–COVID-19 and is even more true now. There are already examples from across the globe and within the United States that show how these may be possible. Although there are still many unknowns around how the design, targeting, level, sequencing, integration, and implementation of fiscal policies together can maximize their NCD prevention potential, there is already clear evidence that health taxes and particularly sugar-sweetened beverage (SSB) taxes are cost-effective. Nonetheless, policies alone may not succeed. Political will to prioritize well-being, protections against industry interference, and public buy-in are necessary. If those elements align, pricing policies that consider the context in question can be designed and implemented to achieve several goals around reducing consumption of unhealthy SSBs and foods, narrowing existing nutritional and health disparities, encouraging economic and social development. The US and its local and state jurisdictions should consider these pricing policy issues and their contexts carefully, in collaboration with community partners and researchers, to design multi-duty actions and to be prepared for future windows of opportunities to open for policy passage and implementation.
APA, Harvard, Vancouver, ISO, and other styles
3

Wasi, Chantapong. Virus Diseases: The Global Challenge to Health for All. Asia-Pacific Congress of Medical Virology (2nd) Held in Bangkok, Thailand on November 17-22, 1991. Abstracts. Fort Belvoir, VA: Defense Technical Information Center, July 1992. http://dx.doi.org/10.21236/ada258158.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mccabe, Kirsten, and Rebecca McDonald. Global Disease Modeling & Forecasting Center. Office of Scientific and Technical Information (OSTI), October 2020. http://dx.doi.org/10.2172/1671063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Deshpande, Alina. RED Alert – Early warning or detection of global re-emerging infectious disease (RED). Office of Scientific and Technical Information (OSTI), July 2016. http://dx.doi.org/10.2172/1261795.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kelly, Luke. Characteristics of Global Health Diplomacy. Institute of Development Studies (IDS), June 2021. http://dx.doi.org/10.19088/k4d.2021.09.

Full text
Abstract:
This rapid review focuses on Global Health Diplomacy and defines it as a method of interaction between the different stakeholders of the public health sector in a bid to promote representation, cooperation, promotion of the right to health and improvement of health systems for vulnerable populations on a global scale. It is the link between health and international relations. GHD has various actors including states, intergovernmental organizations, private companies, public-private partnerships and non-governmental organizations. Foreign policies can be integrated into national health in various ways i.e., designing institutions to govern practices regarding health diplomacy (i.e., health and foreign affairs ministries), creating and promoting norms and ideas that support foreign policy integration and promoting policies that deal with specific issues affecting the different actors in the GHD arena to encourage states to integrate them into their national health strategies. GHD is classified into core diplomacy – where there are bilateral and multilateral negotiations which may lead to binding agreements, multistakeholder diplomacy – where there are multilateral and bilateral negotiations which do not lead to binding agreements and informal diplomacy – which are interactions between other actors in the public health sector i.e., NGOs and Intergovernmental Organizations. The US National Security Strategy of 2010 highlighted the matters to be considered while drafting a health strategy as: the prevalence of the disease, the potential of the state to treat the disease and the value of affected areas. The UK Government Strategy found the drivers of health strategies to be self-interest (protecting security and economic interests of the state), enhancing the UK’s reputation, and focusing on global health to help others. The report views health diplomacy as a field which requires expertise from different disciplines, especially in the field of foreign policy and public health. The lack of diplomatic expertise and health expertise have been cited as barriers to integrating health into foreign policies. States and other actors should collaborate to promote the right to health globally.
APA, Harvard, Vancouver, ISO, and other styles
7

Elledge, Myles, Jennifer Hoponick Redmon, Keith Levine, Rajitha Wickremasinghe, Kamani Wanigasariya, and Roshini Peiris-John. Chronic kidney disease of unknown etiology in Sri Lanka: Quest for understanding and global implications. RTI Press, May 2014. http://dx.doi.org/10.3768/rtipress.2014.rb.0007.1405.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Adlakha, Deepi, Jane Clarke, Perla Mansour, and Mark Tully. Walk-along and cycle-along: Assessing the benefits of the Connswater Community Greenway in Belfast, UK. Property Research Trust, 2021. http://dx.doi.org/10.52915/ghcj1777.

Full text
Abstract:
Physical inactivity is a risk factor for numerous chronic diseases, and a mounting global health problem. It is likely that the outdoor physical environment, together with social environmental factors, has a tendency to either promote or discourage physical activity, not least in cities and other urban areas. However, the evidence base on this is sparse, making it hard to identify the best policy interventions to make, at the local or city level. This study seeks to assess the impact of one such intervention, the Connswater Community Greenway CCG), in Belfast, in Northern Ireland, UK. To do that it uses innovative methodologies, ‘Walk-along’ and ‘Cycle-along’ that involve wearable sensors and video footages, to improve our understanding of the impact of the CCG on local residents. The findings suggest that four characteristics of the CCG affect people’s activity and the benefits that the CCG created. These are physical factors, social factors, policy factors and individual factors. Each of these has many elements, with different impacts on different people using the greenway.
APA, Harvard, Vancouver, ISO, and other styles
9

Thompson, Joseph. How WASH Programming has Adapted to the COVID-19 Pandemic. Institute of Development Studies (IDS), December 2020. http://dx.doi.org/10.19088/slh.2021.001.

Full text
Abstract:
Since first appearing at the end of 2019, the novel coronavirus disease (COVID-19) has spread at a pace and scale not seen before. On 11 March 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. A rapid response was called for, and actors across the globe worked quickly to develop sets of preventative measures to contain the disease. One mode of transmission identified early on in the crisis was via surfaces and objects (fomites) (Howard et al. 2020). To combat this, hand hygiene was put forward as a key preventative measure and heralded as ‘the first line of defence against the disease’ (World Bank 2020). What followed was an unprecedented global focus on handwashing with soap. Health messages on how germs spread, the critical times at which hands should be washed, and methods for correct handwashing were shared (Centers for Disease Control and Prevention 2020). Political leaders around the world promoted handwashing and urged people to adopt the practice to protect against the coronavirus. The primary and secondary impacts of COVID-19 have affected people and industries in a variety of different ways. For the WASH sector, the centring of handwashing in the pandemic response has led to a sudden spike in hygiene activity. This SLH Rapid Topic Review takes stock of some of the cross-cutting challenges the sector has been facing during this period and explores the adaptations that have been made in response. It then looks forwards, thinking through what lies ahead for the sector, and considers the learning priorities for the next steps.
APA, Harvard, Vancouver, ISO, and other styles
10

Gordoncillo, Mary Joy N., Ronello C. Abila, and Gregorio Torres. The Contributions of STANDZ Initiative to Dog Rabies Elimination in South-East Asia. O.I.E (World Organisation for Animal Health), January 2016. http://dx.doi.org/10.20506/standz.2789.

Full text
Abstract:
A Grant Agreement between the Government of Australia and the World Organisation for Animal Health (OIE), the Stop Transboundary Animal Diseases and Zoonoses (STANDZ), initiative includes a rabies component with an overarching intended outcome of reducing dog rabies incidence in targeted areas. This initiative envisaged regional rabies activities in South-East Asia as well as specifically designed pilot projects in the Philippines, Myanmar and Cambodia. While remaining anchored to the envisioned outcome, its implementation from 2013 to 2016 also leveraged on the resources made available through the initiative to strategically generate tools, materials and examples that can potentially bridge long-standing gaps on dog rabies elimination in the region. This included developing approaches on rabies communication strategy, risk-based approach for the prioritization of mass dog vaccination, rabies case investigation, post-vaccination monitoring, building capacity through pilot vaccination projects, One Health operationalization at the grass-root level, and reinforcing high-level political support through regional and national rabies strategy development. These are briefly described in this paper and are also further detailed in a series of publications which individually document these approaches for future utility of the countries in the region, or wherever these may be deemed fitting. The STANDZ rabies initiative leaves behind a legacy of materials and mechanisms that can potentially contribute in strategically addressing rabies in the region and in achieving the global vision of eliminating dog-mediated human rabies by 2030.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography